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1D – one dimensional 
2D – two dimensional 
CD – circular dichroism  
CPS – control peanut sample 
cCBB – colloidal Coomassie Brilliant Blue 
CHAPS – 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
DPS – digested peanut sample 
DTT – dithiothreitol 
ELISA – enzyme-linked immunosorbent assay 
FDR – false discovery rate 
IAA – iodoacetamide 
IPG – immobilised pH gradient 
nLC-MS/MS – nano-liquid chromatography coupled to tandem mass spectrometry 
PBS – phosphate buffered saline 
SDRPs – short digestion resistant peptides (<10 kDa) 
















α-Amylase from human saliva (EC 3.2.1.1; A0521-500 UN; Type IX-A, lyophilized powder 
1000–3000 U/mg protein) and porcine pepsin from gastric mucosa (EC 3.4.23.1; P6887-1G, 
lyophilized powder 3200–4500 U/mg protein) were purchased from Sigma–Aldrich (St. 
Louis, MO, USA). The enzyme activities were measured according to the assays detailed by 
Minekus et al. [1]. Chemicals for gel electrophoresis as Tris(Hydroxymethyl)aminomethane 
(Tris), glycine, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), 
urea, thiourea, dithiotritol (DTT), dimethylformamide, acrylamide, bis-acrylamide, 
trichloroacetic acid (TCA), Coomassie Brilliant Blue R-250 (CBB), and iodoacetamide 
(IAA), sequencing grade trypsin, formic acid, and acetonitrile of HPLC grade were also 
purchased from Sigma-Aldrich. Ampholytes and immobilised pH gradient (IPG) strips were 
supplied by GE Healthcare (Uppsala, Sweden). All other chemicals were of the analytical 
reagent grade, and Milli-Q water (18 MΩ cm at 25 °C) was used (Millipore, Bedford, MA, 
USA) in all the experiments.  
 
Simulated oral and gastric in vitro digestion conditions  
Oral phase: Solid milled peanut (0.4 g) was mixed with 320 μL SSF stock solution. Human 
salivary α-amylase (40 μL, 1500 U/mL in water) was added to achieve a final concentration 
of 75 U/mL in the digestion mixture, followed by addition of CaCl2 (40 μL, 15 mM) to 
achieve final concentration of 0.75 mM. The reaction mixture was incubated for 2 minutes at 
37 °C with agitation. All reagents were previously pre-warmed at 37 °C for 5 minutes. 
Controls without peanut (solid peanut replaced by sand) and controls without amylase 
(amylase replaced by water) were also included. 
Gastric phase: Complete oral phase material was mixed with 400 μL of SGF stock solution 
and 8 μL of CaCl2 (15 mM) to achieve a final concentration of 75 µM in the digestion 
mixture. Porcine pepsin (320 μL; 10,000 U/mL 10 mM HCl) was added, to achieve a final 
concentration of 2000 U/mL in the digestion mixture. The mixture was adjusted to pH 3 with 
1 M HCl, then water was added, such that the final volume of reaction mixture was 1600 μL. 
The reaction mixture was incubated for 120 minutes at 37 °C with intense agitation (600 
rpm). Control samples were run in parallel: pepsin control (oral bolus without amylase with 
addition of 160 μL 10 mM HCl instead of pepsin solution) at 0` (P0) and 120` (P120), and 
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peanut control (with 0.4 mL of SSF stock solution and 0.4 g of sand instead of oral bolus) at 
120` (C120). Digestion was stopped by addition of 200 μL 1 M NaHCO3 to change the pH of 
the final reaction mixture to 8. The samples were centrifuged at 10,000 g for 20 minutes; the 
liquid phase was separated from solid material and immediately frozen at −20 °C. Protein 
concentration was determined using BCA assay (Thermo Fisher Scientific Inc., Bremen, 
Germany) after diluting the liquid phase of digestion mixtures 20 times in phosphate buffered 
saline (PBS). 
Identification of digested peanut proteins  
Identification of peanut proteins was performed by PEAKS Studio 8.5 (Bioinformatics 
Solutions Inc., Canada). Signature MS/MS spectra were searched using PEAKS DB 
algorithm against a hybrid database consisting of a UniprotKB/Swiss-Prot (reviewed only) 
peanut (Arachis hypogaea) database (downloaded on 14/08/2017 from 
http://www.uniprot.org/) and cRAP (The common Repository of Adventitious Proteins) 
database (downloaded on 18/01/2017 from http://www.thegpm.org/crap/). The following 
modifications were taken into account as variables: oxidation (Met), deamidation (Gln, Asn), 
and hydroxylation (Pro), while carbamidomethylation (Cys) was set as fixed. Up to 2 missed 
cleavages with non-specific cleavage at both ends of a peptide were allowed. Mass tolerances 
were set to ±10 ppm for parent ions and ±0.5 Da for fragment ions. Protein filters were as 
follows set to a one unique peptide and -10logP of value 20. Peptide filters were as follows:  
input of -10logP for Peptide-Spectrum Matches (PSM) was the lowest values securing less 
than 0.5% of resulting peptide sequence FDR and 0% FDR at protein level and de novo ALC 
Score ≥ 80%. 
1D SDS-PAGE was performed on a 14% gels  according to Laemmli method [2], stained 
with CBB. Dried TCA/acetone protein pellets from liquid portion of gastric-simulated digesta 
were re-suspended in Laemmli sample buffer (reducing and non-reducing conditions). 
Isoelectrofocusing and 2D SDS-PAGE were done as per method of Apostolovic et al. [3]. 
Briefly, dried TCA/acetone pellets were re-suspended in isoelectrofocusing rehydration 
buffer (8 M Urea, 2% CHAPS, 0.5% IPG buffer 3-10NL, 50 mM DTT, and 0.002% 
bromophenol blue). Protein samples (250 μg) were applied on 13 cm; pH 3–10, nonlinear 
IPG strips (GE Healthcare, Uppsala, Sweden). Isoelectrofocusing was done with Ettan 
IPGphor system (GE Healthcare) and strips were reduced with DTT, and alkylated with IAA 
according to the method of Apostolovic et al. [3]. The second dimension was carried out on 
14% gels, and protein spots were visualized with colloidal CBB staining. The 2D gels were 
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scanned with Typhoon FLA 7000 (GE Healthcare) and spots were quantified and matched 
with Image Master 2D Platinum software v7.0 (GE Healthcare). 
Separation of SDRPs obtained after gastric-simulated digestion and their analyses with 
Orbitrap shotgun peptidomics identification 
Ethanol (2.4 mL) was added to 800 μL of liquid phase separated from the digestion mixture 
and incubated at 4 °C for 20 hours. After centrifugation at 4 °C and 12,000 g for 10 minutes, 
the supernatant containing the released SDRPs was separated and dried in a vacuum 
concentrator in low binding tubes. The dried peptides were dissolved in 500 μL of 10 mM 
HCl and subjected to size-exclusion chromatography. The Sephadex G25 column (0.8 × 30 
cm) was equilibrated, and the separation was carried out with 10 mM HCl at a flow rate of 5 
mL/h at room temperature. Fractions of 500 μL were collected, and the separation was 
monitored by ultraviolet absorption at 214 nm, 280 nm, and 220 nm (Figure S1). To 
minimize low molecular mass species other than peptides (such as polyphenols), fractions 
with highest absorbance values at 214 nm and lowest absorbance values at 280 and 340 nm 
(fractions 8–20 Figure S1) were pooled, and were analysed by electrophoresis and 
immunoblotting with Ara h 2 antibodies to confirm the absence of intact allergens. They were 
then divided into two parts. One part was concentrated 4 times on SpeedVac (Eppendorf, 
Hamburg, Germany) and used for the ImmunoCAP inhibition assay. The second part was 
evaporated, and then subjected to nLC-MS/MS analysis as intact or pre-treated by reduction, 
alkylation, and trypsin digestion according to the method of Johnson et al. [4], where 
reduction time was prolonged to 1.5 hours at 80 °C. The peptides obtained were analysed 
according to the method reported by Apostolovic et al. [3, 5] using LTQ Orbitrap XL mass 
spectrometer with an EASY- nano liquid chromatography (nLC) II system (Thermo Fisher 
Scientific Inc., Bremen, Germany), with change in the Orbitrap resolution from 30000 to 
60000. Identification of peanut peptides was performed using PEAKS Studio 8.5 
(Bioinformatics Solutions Inc., Canada). Signature MS/MS spectra were searched using 
PEAKS DB algorithm against a hybrid database consisting of a UniprotKB/Swiss-Prot 
(reviewed only) peanut (Arachis hypogaea) database (downloaded on 14/08/2017 from 
http://www.uniprot.org/) and cRAP (The common Repository of Adventitious Proteins) 
database (downloaded on 18/01/2017 from http://www.thegpm.org/crap/). The following 
modifications were taken into account as variables: oxidation (Met), deamidation (Gln, Asn), 
and hydroxylation (Pro), while carbamidomethylation (Cys) was set as fixed. Up to 2 missed 
cleavages with non-specific cleavage at both ends of a peptide were allowed. Mass tolerances 
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were set to ±10 ppm for parent ions and ±0.8 Da for fragment ions. Protein filters were as 
follows set to a one unique peptide and -10logP of value 20. Peptide filters were as follows:  
input of -10logP for Peptide-Spectrum Matches PSM was the lowest values securing less than 
0.5% of resulting peptide sequence FDR and 0% FDR at protein level and de novo ALC 
Score ≥ 80%. Identified peptides were searched in the IEDB database (Immuno Epitope 
Database and Analysis, http://www.iedb.org) in order to find sequences overlapping with 
characterized epitopes. The following IEDB search parameters were applied: linear sequence 
for epitope structure, substring for BLAST option, and human as host.  
 
IgE-binding properties of peanut digests 
ELISA inhibition. The IgE-binding properties of the liquid phase from the digestion 
mixtures, as well as standard defatted peanut extracts were analysed using an inhibition 
ELISA. Standard defatted raw peanut extract was prepared according to the method reported 
by Radosavljevic et al. [6]. Half-area microtiter plates (96 wells, Greiner bio-one, 
Frickenhausen, Germany) were coated with 50 μL per well of 10 μg/mL with defatted peanut 
extract, and incubated overnight at 4 °C in coating buffer (15 mM Na2CO3, 35 mM NaHCO3 
pH 9.6). The remaining binding sites were blocked with 1% BSA in TPBS (20 mM 
phosphate buffer with 0.9% NaCl pH 7.4 containing 0.05% of Tween 20 (w/v)), for 1 hour at 
37 °C. Serum pooled from 10 peanut sensitised patients (patient #1-10, Table S3) was 
prepared by following the EMEA Note for Guidance on Allergen Products 
(EMEA/CHMP/BWP/304831/2007). Samples (defatted raw peanut extract, defatted liquid 
phase of control and digested peanut) were diluted 2-fold with 1% BSA in tPBS 
(concentration range 10–0.04 µg/mL). Samples were pre-incubated 1:1 with the serum pool 
(final dilution of serum pool was 30-fold in blocking buffer) for 1 hour at 37 °C before their 
addition on the plate for incubation of 1 hour at 37 °C. Detection of bound IgE was 
performed with 50 μL mouse-anti-human IgE monoclonal antibody (2000 times diluted in 
TPBS containing 1% BSA; Abcam, Cambridge, UK) conjugated to horseradish peroxidase. 
Finally, staining was performed by enzymatic conversion of 3, 3′, 5, 5′-tetramethylbenzidine 
(Biolegend, San Diego, CA, USA). Inhibition of IgE-binding was calculated as [(ODno inhibitor 
– ODinhibitor)/OD no inhibitor] × 100, and the concentration needed to inhibit 50% of this signal 





ImmunoCAP inhibition. IgE-binding of the SDRPs fraction of digested peanut was 
determined using ImmunoCAP inhibition (ImmunoCAP System, Phadia/Thermo Fisher 
Scientific, Uppsala, Sweden). Seven undiluted individual sera (200 µL; patients #1–7 Table 
S2) were pre-incubated with 200 µL peptides prior to the measurement for allergen-specific 
IgE to: peanut (f13), Ara h 1 (f422), Ara h 2 (f423) and Ara h 3 (f424). Applied peptides are 
released from about 3.3 mg of milled peanut e.g. released from about 800 µg of peanut 
proteins extracted to liquid phase during digestion. The inhibition of IgE-binding was 
expressed as percentage based on non-inhibited serum, using the following formula: % IgE 
inhibition = 100 – (IgE binding to the solid surface in the presence of the inhibitor/IgE 
binding to the solid surface) × 100). 
 
Immunoblotting. After TCA precipitation, samples were resuspended in 2% SDS. 1D 
electrophoresis was carried out on a 14% gel. The samples (25 μg) were loaded in the well. 
Proteins were separated on 1-DE and transferred onto nitrocellulose membranes with 0.2 µm 
pore size (Bio-Rad, Solna, Sweden). Ponceau S staining was used to verify success of the 
transfer. The membranes were blocked with 2% BSA in PBS pH 7.4 containing 0.05% 
Tween 20 (TPBS) for 1 hour at room temperature (RT). Subsequently, membrane was 
incubated overnight at 4 °C with 1:10 diluted serum pool from patients with proven peanut 
allergy. The serum pool consisted of sera of seven peanut sensitised patients (#4-10 Table S3; 
range and mean of total peanut-specific IgE: 11- 415 kU/L and 146 kU/L, respectively; range 
and mean of Ara h 2-specific IgE: 5–192 kUA/L and 61 kUA/L, respectively). The secondary 
antibody, anti-human IgE produced in rabbit (Miab, Uppsala, Sweden), was diluted 1:2000 
and incubated for 1 hour at RT. Tertiary antibody, AP-labelled goat anti-rabbit IgG (Jackson 
ImmunoResearch, West Grove, PA, USA), diluted 1:2000, was added to the strips and 
incubated for 1 hour at RT. The binding patterns were visualized with a substrate solution 
consisting of 1.5 mg BCIP and 3 mg NBT in 10 mL of 100 mM Tris, containing 150 mM 
NaCl, and 5 mM MgCl2, pH 9.6. 
 
Circular Dichroism (CD) Spectroscopy 
CD spectroscopy was performed on control and digested samples after re-solubilization of 
TCA/acetone pellet in 2% SDS. Samples were diluted in 10 mM sodium phosphate buffer 
(pH 7.4) to achieve final concentrations of 1 mg/mL for far-UV CD (SDS concentration was 
< 0.2 %). Far UV CD spectra were recorded using a Jasco J-815 spectrophotometer (Japan 
Spectroscopic Co. Ltd., Tokyo, Japan) at RT. 
8 
 
De novo modelling and molecular graphics 
The sequences of Ara h 1, Ara h 2, Ara h 3 and Ara h 6 were obtained from UniProt 
(www.uniprot.org, identifiers P43238, Q6PSU2-2, B5TYU1 and A5Z1R0, respectively). For 
Ara h 6 structure PDB code 1W2Q, model #1 was used. The missing regions in the Ara h 1, 
Ara h 2.01 and Ara h 3 partial crystal structures (PDB code 3SMH, 3OB4 and 3C3V, 
respectively) [7] were built using Rosetta all-atom de-novo loop modelling. After clustering 
of 10,000 modelled structures (per protein) by structural similarity, the lowest energy models 
of the most populated cluster were chosen (Figures 2 and 5). Molecular graphics of Ara h 1, 
Ara h 2, Ara h 3 and Ara h 6 3D modelled structures were created using BIOVIA Discovery 
Studio Visualizer (Dassault Systems BIOVIA, Discovery Studio Modelling Environment, 


























Table S1.  Summary of published data on major peanut allergens digestibility by in vitro 




































nd 170 2.5 PP 120 < 10 <4 [8] 
0.025 80 2.1 PP   1 <20 [9]  
0.05 162 2.5 PP 120 1 5.5 [10] 
12.8 nd 1.2 PP 120 5 nd [11] 
3.04 10,000 1.2 PP 60 0.5 nd [12] 
0.3 1,000 1.2 PP 60 0.5 nd [12] 
0.03 100 1.2 PP 60 0.5 nd [12] 
3.04 10,000 1.2 PE 60 0.5 nd [12] 
0.63 2540 1.2 PE 60 1 nd [13] 
0.0001 nd 2 PE 1200 30 <35  [14] 
Ara h 2, 




3 10,000 1.2 PP 60 0-2 10 [15] 
3 10,000 2 PP 60 0-30 10 [15] 
19 nd 1.2 PP 60 / / [16] 
12.8 nd 1.2 PP 120 0.5 nd [11] 
3.04 10,000 1.2 PP 60 16 10 [12] 
0.3 1,000 1.2 PP 60 / / [12] 
0.03 100 1.2 PP 60 / / [12] 
3.04 10,000 1.2 PE 60 16 / [12] 
0.63 2540 1.2 PE 60 15 nd [13] 







3.04 10,000 1.2 PP 60 0.25 nd [12] 
0.3 1,000 1.2 PP 60 0.25 nd [12] 
0.03 100 1.2 PP 60 0.25 nd [12] 
0.002 nd 2 PP 120 <2 <14 [17] 
3.04 10,000 1.2 PE 60 0.25 nd [12] 
0.63 2540 1.2 PE 60 1 nd [13] 
Ara h 6 




3.04 10,000 1.2 PP 60 4 10 [12] 
0.3 1,000 1.2 PP 60 16 10 [12] 
0.03 100 1.2 PP 60 / / [12] 
3.04 10,000 1.2 PE 60 60 10 [12] 
0.63 2540 1.2 PE 60 15 nd [13] 





Table S2. Stock solutions preparation for simulated digestive fluids. 
Constituent 







SGF stock solution 
Final concentration in 
gastric phase reaction 
mixture 
KCl 15.1 mM 6.04 mM 6.9 mM 6.67 mM 
KH2PO4 3.7 mM 1.48 mM 0.9 mM 1.19 mM 
NaHCO3 13.6 mM 5.44 mM 25 mM 15.22 mM 
NaCl - - 47.2 mM 23.6 mM 
MgCl2 
(H2O)6 
0.15 mM 0.06 mM 0.1 mM 0.08 mM 
(NH4)CO3 0.06 mM 0.024 mM 0.5 mM 0.263 mM 
HCl 1.1 mM 0.44 mM 240 mM 122.45 mM 
pH 7.05 6.68±0.12 3.00 2.91±0.18 
 
 
Table S3. IgE levels of peanut sensitized patients determined by ImmunoCAP 
Patient’s ID Whole peanut extract rAra h 1 rAra h 2  rAra h 3  
 kUA/L 
1 415 96 192 52 
2 11 <0.10 5 <0.10 
3 65 12.40 36 6.40 
4 48 14 20 2.60 
5 34 2.60 24 0.66 
6 152 2.40 78 <0.20 
7 218 92 68 34 
8 225 66 63 3.90 
9 23 0.19 0.24 0.58 
10 11 3.20 0.14 <0.10 
 
 
Table S4 is provided separately as pdf file. It contains identification results of proteins and 
their fragments from spots and bands of standard peanut extract (SPE), control peanut (CPS) 
and digested peanut samples (DPS) from Figs. 1, 3 and 2S achieved by tandem bottom up 
proteomics on Orbitrap LTQ hybrid and PEAKS Suite 8.5 softwares 
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Table S5. Sequences of intact SDRPs from Ara h 3 (18) and Ara h 1 (27), found after in vitro 
oral-gastric digestion of whole kernels peanut, matching with Ara h 3 and Ara h 1 epitopes 
reported in IEDB. The SDRPs fraction was analyzed by mass spectrometry as intact. Epitopes 









Epitope sequence IEDB Reference 




106026 QARQLKNNNPFKFFV [18] 
1 LKNNNPFKF 106042 QLKNNNPFKFFVPPS [18] 
2 RQLKNNNPFKF 




106026 QARQLKNNNPFKFFV [18] 
3 SYGLPRE 
Ara h 3 
(A1DZF0) 
105678 ANSYGLPREQARQLK [18] 




99266 GDLIAVPTGVAFWLY [19] 
4 IAVPTGVAF 99325 IAVPTGVAFWLYNDH [19] 




53687 RFDEGDLIAVPTGVA [6] 
5 IAVPTGVA 99266 GDLIAVPTGVAFWLY [19] 
5 IAVPTGVA 99325 IAVPTGVAFWLYNDH [19] 
6 RILSPDRK 
Ara h 3 
(A1DZF0) 
71559 VTVRGGLRILSPDRK [20]; [6] 
6 RILSPDRK 99738 TVRGGLRILSPDRKR [18]; [19] 
6 RILSPDRK 70725 VRGGLRILSPDRKRR [6] 
6 RILSPDRK 99277 GGLRILSPDRKRRAD [19] 
6 RILSPDRK 105826 GGLRILSPDRKRRQQ [18] 
6 RILSPDRK 106076 RILSPDRKRRQQYER [18] 
7 KKNIGRNRSPDIYNPQAG
SL 
Ara h 3 
(A1DZF0) 
31642 KKNIGRNRSPDIYNP [18]; [19]; [6] 
7 KKNIGRNRSPDIYNPQAG
SL 
99331 IGRNRSPDIYNPQAG [18]; [19]; [6] 
8 RSPDIYNPQAGSL 
Ara h 3 
(A1DZF0) 
99513 NRSPDIYNPQAGSLK [18]; [19] 
9 SPDIYNPQAGSL 
Ara h 3 
(A1DZF0) 
99513 NRSPDIYNPQAGSLK [18]; [19] 
10 LRGRAHVQVVD Ara h 3 
(A1DZF0) 
99363 IYRLRGRAHVQVVDS [19] 
10 LRGRAHVQVVD 99447 LRGRAHVQVVDSNGN [19] 
11 LRGRAHVQVVDSNG Ara h 3 
(A1DZF0) 
99447 LRGRAHVQVVDSNGN [19] 
12 ARQLKNNNPFKF Ara h 3 
(Q6IWG5) 
106026 QARQLKNNNPFKFFV [18] 
13 NGRAHVQVVDSNGNRVY
DE 
Ara h 3 
(Q6IWG5, 
Q0GM57) 
99597 RAHVQVVDSNGNRVY [19] 
14 NGRAHVQVVDSNGNRVY
D 
Ara h 3 
(Q6IWG5, 
Q0GM57) 
99597 RAHVQVVDSNGNRVY [19] 




99597 RAHVQVVDSNGNRVY [19] 




99447 LRGRAHVQVVDSNGN [19] 




99141 DEELQEGHVLVVPQN [19] 
16 LQEGHVL 99440 LQEGHVLVVPQNFAV [19] 




99280 GHVLVVPQNFAVAGK [19] 
17 GHVLVVPQNF 99440 LQEGHVLVVPQNFAV [19] 




99280 GHVLVVPQNFAVAGK [19] 
18 HVLVVPQNF 99440 LQEGHVLVVPQNFAV [19] 
19 VLPKHADADNIL Ara h 1 100389 PNTLVLPKHADADNILVIQQ [21] 
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190791 IEAKPNTLVLPKHADADNIL [22] 






100389 PNTLVLPKHADADNILVIQQ [21] 
20 VLPKHADADNI 190791 IEAKPNTLVLPKHADADNIL [22] 






99393 KPNTLVLPKHADADN [19] 
21 VLPKHADADN 100389 PNTLVLPKHADADNILVIQQ [21] 
21 VLPKHADADN 190791 IEAKPNTLVLPKHADADNIL [22] 






99393 KPNTLVLPKHADADN [19] 
22 VLPKHADAD 100389 PNTLVLPKHADADNILVIQQ [21] 
22 VLPKHADAD 190791 IEAKPNTLVLPKHADADNIL [22] 






100389 PNTLVLPKHADADNILVIQQ [21] 
23 PKHADADNIL 190791 IEAKPNTLVLPKHADADNIL [22] 
23 PKHADADNIL 190849 LPKHADADNILVIQQGQATV [22] 
23 PKHADADNIL 523624 PKHADADNILVIQQGQATVTVANG [23] 






190849 LPKHADADNILVIQQGQATV [22] 
24 PKHADADNILVI 523624 PKHADADNILVIQQGQATVTVANG [23] 
24 PKHADADNILVI 100389 PNTLVLPKHADADNILVIQQ [21] 






99616 RKSFNLDEGHALRIP [19]; [24] 
25 SFNLDEGHA 190952 RKSFNLDEGHALRIPSGFIS [22] 
25 SFNLDEGHA 191006 TVTVANGNNRKSFNLDEGHA [22] 
26 LRIPSGF 






99142 DEGHALRIPSGFISY [19] 
26 LRIPSGF 99312 HALRIPSGFISYILN [19] 
26 LRIPSGF 100063 GHALRIPSGFISYILNRHDN [21] 
26 LRIPSGF 190781 HALRIPSGFISYILNRHDNQ [22] 
26 LRIPSGF 190952 RKSFNLDEGHALRIPSGFIS [22] 
27 LRIPSGFI 






99142 DEGHALRIPSGFISY [19] 
27 LRIPSGFI 99312 HALRIPSGFISYILN [19] 
27 LRIPSGFI 100063 GHALRIPSGFISYILNRHDN [21] 
27 LRIPSGFI 190781 HALRIPSGFISYILNRHDNQ [22] 
27 LRIPSGFI 190952 RKSFNLDEGHALRIPSGFIS [22] 






100169 ISYILNRHDNQNLRVAKISM [22]; [21] 
28 ILNRHDNQNL 99355 ISYILNRHDNQNLRV [19]; [24] 






100169 ISYILNRHDNQNLRVAKISM [22]; [21] 
29 RVAKISM 99511 NQNLRVAKISMPVN [19];[24]; [25] 
29 RVAKISM 100433 QNLRVAKISMPVNTPGQFED [21] 
29 RVAKISM 190882 NQNLRVAKISMPVNTPGQFE [22] 






100433 QNLRVAKISMPVNTPGQFED [21] 
30 AKISMPVNTPGQF 190882 NQNLRVAKISMPVNTPGQFE [22] 
30 AKISMPVNTPGQF 434773 VAKISMPVNTPGQFEDFFPASSR + 
MCM(K3) 
[26] 
30 AKISMPVNTPGQF  VAKISMPVNTPGQFEDFFPASSR [26] 






98841 KAMVIVVVNKGTGNLELVAV [27]; [21]; 
[28] 
31 VVVNKGTGNLE 148699 NSKAMVIVVVNKGTGNLELV [29] 
31 VVVNKGTGNLE 190708 AMVIVVVNKGTGNLELVAV [22] 
31 VVVNKGTGNLE 523259 NSKAMVIVVVNKGTGNLELVAVRK [23] 




32 VKVSKEHVEE (P43238, 
N1NG13) 
99757 VIVKVSKEHVEELTK [19] 
32 VKVSKEHVEE 100323 NEGVIVKVSKEHVEELTKHA [21]; [22]; 
[31] 
32 VKVSKEHVEE 106968 VKVSKEHVEELTKHAKSVSK [31] 




99657 SEEEGDITNPINLRE [19] 
33 SEEEGDITNPINL 190971 SEEEGDITNPINLREGEPDL [22] 






100137 IFLAGDKDNVIDQIEKQAKD [22]; [21] 
34 LAGDKDNVIDQI 434746 IFLAGDKDNVIDQIEK + MCM(K7) [26] 
34 LAGDKDNVIDQI 434747 IFLAGDKDNVIDQIEK [26] 






100137 IFLAGDKDNVIDQIEKQAKD [22]; [21] 
35 LAGDKDNVIDQ 434746 IFLAGDKDNVIDQIEK + MCM(K7) [26] 
35 LAGDKDNVIDQ 434747 IFLAGDKDNVIDQIEK [26] 






98841 KAMVIVVVNKGTGNLELVAV [27]; [21]; 
[28] 
36 IVVVNKGTGNLEL 148699 NSKAMVIVVVNKGTGNLELV [29] 
36 IVVVNKGTGNLEL 190708 AMVIVVVNKGTGNLELVAV [22] 
36 IVVVNKGTGNLEL 523259 NSKAMVIVVVNKGTGNLELVAVRK [23] 
37 IVVVNKGTGNL 






98841 KAMVIVVVNKGTGNLELVAV [27]; [21]; 
[28] 
37 IVVVNKGTGNL 148699 NSKAMVIVVVNKGTGNLELV [29] 
37 IVVVNKGTGNL 190708 AMVIVVVNKGTGNLELVAV [22] 
37 IVVVNKGTGNL 523259 NSKAMVIVVVNKGTGNLELVAVRK [23] 
37 IVVVNKGTGNL 99364 KAMVIVVVNKGTGNL [24]; [19] 
38 IVKVSKE 






98910 NEGVIVKVSKEHVEE [19]; [30]; 
[24] 
38 IVKVSKE 100323 NEGVIVKVSKEHVEELTKHA [21]; [22]; 
[31] 
38 IVKVSKE 99757 VIVKVSKEHVEELTK [19] 
38 IVKVSKE 190967 RWSTRSSENNEGVIVKVSKE [22] 
38 IVKVSKE 191030 WSTRSSENNEGVIVKVSKE [22] 






148649 KEGDVFIMPAAHPVAINASS [22]; [29] 
39 IMPAAHPVAINA 99167 DVFIMPAAHPVAINA [19] 
39 IMPAAHPVAINA 190764 GDVFIMPAAHPVAINASS [22] 






148649 KEGDVFIMPAAHPVAINASS [22]; [29] 
40 IMPAAHPVAIN 99167 DVFIMPAAHPVAINA [19] 
40 IMPAAHPVAIN 190764 GDVFIMPAAHPVAINASS [22] 
41 IMPAAHPVA 






148649 KEGDVFIMPAAHPVAINASS [22]; [29] 
41 IMPAAHPVA 99167 DVFIMPAAHPVAINA [19] 
41 IMPAAHPVA 190764 GDVFIMPAAHPVAINASS [22] 
41 IMPAAHPVA 98843 KEGDVFIMPAAHPVA [19]; [30] 
41 IMPAAHPVA 540385 EGDVFIMPAAHPVAI [24] 
42 EVKPDKKNPQL 






99242 FEVKPDKKNPQLQDL [19] 
42 EVKPDKKNPQL 99283 GKLFEVKPDKKNPQL [19] 
42 EVKPDKKNPQL 148695 NNFGKLFEVKPDKKNPQLQD [29] 
42 EVKPDKKNPQL 190745 EVKPDKKNPQLQ [32]; [22] 
42 EVKPDKKNPQL 190750 FEVKPDKKNPQLQDLDMMLT [22] 
42 EVKPDKKNPQL 190877 NNFGKLFEVKPDKKNPQLQ [22] 
42 EVKPDKKNPQL 523002 NNFGRLFEVKPDKKNPQLQDLDMM [23] 










99242 FEVKPDKKNPQLQDL [19] 
43 EVKPDKKNPQ 99283 GKLFEVKPDKKNPQL [19] 
43 EVKPDKKNPQ 148695 NNFGKLFEVKPDKKNPQLQD [29] 
43 EVKPDKKNPQ 190745 EVKPDKKNPQLQ [32]; [22] 
43 EVKPDKKNPQ 190750 FEVKPDKKNPQLQDLDMMLT [22] 
43 EVKPDKKNPQ 190877 NNFGKLFEVKPDKKNPQLQ [22] 
43 EVKPDKKNPQ 523002 NNFGRLFEVKPDKKNPQLQDLDMM [23] 
43 EVKPDKKNPQ 540393 EVKPDKKNPQLQDLD [24] 
43 EVKPDKKNPQ 190729 DLSNNFGKLFEVKPDKKNPQ [22] 
43 EVKPDKKNPQ 190876 NNFGKLFEVKPDKKNPQ [22] 
44 EEGDITNPINL Ara h 1 
(P43238, 
N1NG13) 
99657 SEEEGDITNPINLRE [19] 
44 EEGDITNPINL 190971 SEEEGDITNPINLREGEPDL [22] 
45 DITNPINL 






98731 DITNPINLRE [30] 
45 DITNPINL 98732 DITNPINLREGEPDL [30] 
45 DITNPINL 99196 EGDITNPINLREGEP [19] 
45 DITNPINL 99657 SEEEGDITNPINLRE [19] 






















Table S6. Sequences of SDRPs from Ara h 3 (30), Ara h 1(28) and Ara h 2 (2), found after in 
vitro oral-gastric digestion of grained peanut, matching with Ara h 3 and Ara h 1 epitopes 
reported in IEDB. The SDRPs fraction was subjected to reduction, alkylation and trypsin 
digestion before mass spectrometry analysis. Epitopes found in identified peptides are bolded 
and reported with their ID.  
Peptide 
No. 




Epitope sequence IEDB Reference 
1 AHVQVVDSNG Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
99447 LRGRAHVQVVDSNGN [19] 
1 AHVQVVDSNG 99597 RAHVQVVDSNGNRVY [19] 
2 ALRRPFYSNAPQE 
Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, Q9SQH7, A1DZF0) 
99484 NALRRPFYSNAPQEI [18]; [19] 
3 IETWNPNNQE 
Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
25997 IETWNPNNQEFECAG [6] 
4 IQQGRGYFG Ara h 3 (Q647H4, Q8LKN1, 
A1DZF0, Q9SQH7) 
16280 FIQQGRGYFGLIFPG [18]; [19]; [6] 
4 IQQGRGYFG 99561 QEIFIQQGRGYFGLI [18]; [19] 
5 LKNNNPFKF Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077,  Q9SQH7) 
106026 QARQLKNNNPFKFFV [18] 
5 LKNNNPFKF 106042 QLKNNNPFKFFVPPS [18] 
6 LQEGHVLVVPQN  99440 LQEGHVLVVPQNFAV [19] 
6 LQEGHVLVVPQN  99141 DEELQEGHVLVVPQN [19] 
7 LQEGHVLVVPQNF 
Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
99440 LQEGHVLVVPQNFAV [19] 
8 LRILSPDR 
Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0 
71559 VTVRGGLRILSPDRK [20]; [6] 
8 LRILSPDR 99738 TVRGGLRILSPDRKR [18]; [19] 
8 LRILSPDR 70725 VRGGLRILSPDRKRR [6] 
8 LRILSPDR 99277 GGLRILSPDRKRRAD [19] 
8 LRILSPDR 105826 GGLRILSPDRKRRQQ [18] 
9 NGRAHVQVVDSNGNR
VYDEE 
 99597 RAHVQVVDSNGNRVY [19] 
10 NIGRNRSPDIYNPQAG Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0) 
99331 IGRNRSPDIYNPQAG [18]; [19]; [6] 
11 NNNPFKF Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
105988 NNNPFKFFVPPSEQS [18] 
11 NNNPFKF 106026 QARQLKNNNPFKFFV [18] 
11 NNNPFKF 106042 QLKNNNPFKFFVPPS [18] 
12 NRSPDIYNPQAG Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0) 
99331 IGRNRSPDIYNPQAG [18]; [19]; [6] 
12 NRSPDIYNPQAG 99513 NRSPDIYNPQAGSLK [18]; [19] 
13 NRSPDIYNPQAGS Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0) 
99513 NRSPDIYNPQAGSLK [18]; [19] 
14 NRSPDIYNPQAGSL Ara h 3 (Q8LKN1, Q6T2T4, 
A1DZF0, Q647H4) 
99513 NRSPDIYNPQAGSLK [18]; [19] 
15 NSYGLPR Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
105678 ANSYGLPREQARQLK [18] 
16 PDIYNPQAGSL Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077) 
99513 NRSPDIYNPQAGSLK [18]; [19] 
17 QEGHVLVVPQNF Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0,  Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
99440 LQEGHVLVVPQNFAV [19] 
18 QLKNNNPFKF Ara h 3 (Q6IWG5, Q0GM57, 
E5G077, Q9SQH7, Q647H4, 
Q8LKN1, Q6T2T4, A1DZF0) 
106026 QARQLKNNNPFKFFV [18] 
18 QLKNNNPFKF 106042 QLKNNNPFKFFVPPS [18] 
19 RAHVQVVDSNGNRVY
DEE 
Ara h 3 (A1DZF0, Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
99597 RAHVQVVDSNGNRVY [19] 
20 RPFYSNAPQE Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q9SQH7 
99484 NALRRPFYSNAPQEI [18]; [19] 
21 RPFYSNAPQEI Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
99484 NALRRPFYSNAPQEI [18]; [19] 
22 RSPDIYNPQAGSL Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0) 
99513 NRSPDIYNPQAGSLK [18]; [19] 
23 SLPYSPYSPQ Ara h 3 (Q647H4, Q8LKN1, 106093 RSLPYSPYSPQTQPK [18] 
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23 SLPYSPYSPQ Q6T2T4) 106122 SRRRSLPYSPYSPQT [18] 
24 SLPYSPYSPQTQPK Ara h 3 (Q8LKN1, Q6T2T4) 106093 RSLPYSPYSPQTQPK [18] 
25 SPDIYNPQAG Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0) 
99331 IGRNRSPDIYNPQAG [18]; [19]; [6] 
25 SPDIYNPQAG 99513 NRSPDIYNPQAGSLK [18]; [19] 
26 SPDIYNPQAGSL Ara h 3 (Q647H4, Q8LKN1) 99513 NRSPDIYNPQAGSLK [18]; [19] 
27 SYGLPR Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q9SQH7) 
105678 ANSYGLPREQARQLK [18] 
28 YEEPAQQGR Ara h 3 (Q9SQH7, Q8LKN1, 
Q6T2T4, A1DZF0, Q9SQH7) 
105700 CPSTYEEPAQQGRRH [18] 
28 YEEPAQQGR 106150 TYEEPAQQGRRHQSQ [18] 
29 YEEPAQQGRR Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0) 
105700 CPSTYEEPAQQGRRH [18] 
29 YEEPAQQGRR 106150 TYEEPAQQGRRHQSQ [18] 
30 YGLPR Ara h 3 (Q647H4, Q8LKN1, 
Q6T2T4, A1DZF0, Q6IWG5, 
Q0GM57, E5G077, Q9SQH7) 
105678 ANSYGLPREQARQLK [18] 
30 YGLPR 106196 YGLPREQARQLKNNN [18] 
31 CLQSCQQEPDDLKQK Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
98978 RCLQSCQQEPDDLKQKACES        [21]; [28] 
31 CLQSCQQEPDDLKQK 190885 PCAQRCLQSCQQEPDDLKQK [22] 
32 VVVNKGTGNLE 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
99053 VVNKGTGNLELVAVR        [19]; [30] 
32 VVVNKGTGNLE 148699 NSKAMVIVVVNKGTGNLELV           [29] 
32 VVVNKGTGNLE 190708 AMVIVVVNKGTGNLELVAV           [22] 
32 VVVNKGTGNLE 523259 NSKAMVIVVVNKGTGNLELVA
VRK 
          [23] 
33 VVVNKGTGNL 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
98841 KAMVIVVVNKGTGNLELVAV   [27]; [21]; [28] 
33 VVVNKGTGNL 99364 KAMVIVVVNKGTGNL       [24]; [19] 
33 VVVNKGTGNL 148699 NSKAMVIVVVNKGTGNLELV            [29] 
33 VVVNKGTGNL 190708 AMVIVVVNKGTGNLELVAV            [22] 
33 VVVNKGTGNL 523259 NSKAMVIVVVNKGTGNLELVA
VRK 
           [23] 
34 VVNKGTGNL 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
98841 KAMVIVVVNKGTGNLELVAV    [27]; [21]; 
[28] 
34 VVNKGTGNL 99364 KAMVIVVVNKGTGNL         [24]; [19] 
34 VVNKGTGNL 99053 VVNKGTGNLELVAVR         [19]; [30] 
34 VVNKGTGNL 148699 NSKAMVIVVVNKGTGNLELV [29] 
34 VVNKGTGNL 148985 VVNKGTGNLELVAVRKEQQQ [29] 
34 VVNKGTGNL 190708 AMVIVVVNKGTGNLELVAV [27] 
34 VVNKGTGNL 523259 NSKAMVIVVVNKGTGNLELVA
VRK 
            [23] 
35 SFNLDEGHA 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
99616 RKSFNLDEGHALRIP [24]; [19] 
35 SFNLDEGHA 190952 RKSFNLDEGHALRIPSGFIS [22] 
35 SFNLDEGHA 191006 TVTVANGNNRKSFNLDEGHA [22] 
36 SEEEGDITNPINL 
Ara h 1 (P43238, N1NG13) 
99657 SEEEGDITNPINLRE              [19] 
36 SEEEGDITNPINL 190971 SEEEGDITNPINLREGEPDL [22] 
37 REGEPDLSNNFGKL 
Ara h 1 (P43238, N1NG13) 
98979 REGEPDLSNNFGKLF             [30] 
37 REGEPDLSNNFGKL 190893 PINLREGEPDLSNNFGKLFE [22] 
38 PKHADADNIL 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
100389 PNTLVLPKHADADNILVIQQ [21] 
38 PKHADADNIL 190791 IEAKPNTLVLPKHADADNIL [22] 
38 PKHADADNIL 190849 LPKHADADNILVIQQGQATV [22] 




Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
99031 TSRNNPFYFPSRRFS          [19]; [30] 
39 NNPFYFPSR 99031 TSRNNPFYFPSRRFS          [19]; [30] 
39 NNPFYFPSR 99607 REETSRNNPFYFPSR              [19] 
39 NNPFYFPSR 100478 RNNPFYFPSRRFSTRYGNQN             [21] 
39 NNPFYFPSR 148966 TSRNNPFYFPSRRFSTRYGN [29] 
39 NNPFYFPSR 190878 NNPFYFPSRRFSTRYGNQNG [22] 
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39 NNPFYFPSR 190973 SHVREETSRNNPFYFPSRRF [22] 
39 NNPFYFPSR 540582 RNNPFYFPSRRFSTR [24] 
40 LAGDKDNVIDQ 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
100137 IFLAGDKDNVIDQIEKQAKD         [22]; [21] 
40 LAGDKDNVIDQ 434746 IFLAGDKDNVIDQIEK + 
MCM(K7) 
[26] 
40 LAGDKDNVIDQ 434747 IFLAGDKDNVIDQIEK             [26] 
41 LAFPGSGEQVEKL 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237) 
98859 LAFPGSGEQVEKLIK             [30] 
41 LAFPGSGEQVEKL 98859 LAFPGSGEQVEKLIK             [30] 
41 LAFPGSGEQVEKL 190804 KDLAFPGSGEQVEKLIKNQK [22] 
42 KGSEEEGDITNPIN Ara h 1 (P43238, N1NG13) 98850 KKGSEEEGDITNPIN          [19]; [30] 
43 IVVVNKGTGNLE 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
98841 KAMVIVVVNKGTGNLELVAV     [27]; [21]; 
[28] 
43 IVVVNKGTGNLE 523259 NSKAMVIVVVNKGTGNLELVA
VRK 
          [23] 
43 IVVVNKGTGNLE 190708 AMVIVVVNKGTGNLELVAV [22] 
43 IVVVNKGTGNLE 148699 NSKAMVIVVVNKGTGNLELV [29] 
44 ISMPVNTPGQF 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
100433 QNLRVAKISMPVNTPGQFED           [21] 
44 ISMPVNTPGQF 190882 NQNLRVAKISMPVNTPGQFE [22] 
44 ISMPVNTPGQF 434773 VAKISMPVNTPGQFEDFFPASS
R + MCM(K3) 
[26] 
44 ISMPVNTPGQF 434774 VAKISMPVNTPGQFEDFFPASS
R 
[26] 
45 IMPAAHPVAINAS Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
190764 GDVFIMPAAHPVAINASS [22] 
45 IMPAAHPVAINAS 148649 KEGDVFIMPAAHPVAINASS [22]; [29] 
46 IMPAAHPVAINA 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
190764 GDVFIMPAAHPVAINASS [22] 
46 IMPAAHPVAINA 148649 KEGDVFIMPAAHPVAINASS [22]; [29] 
46 IMPAAHPVAINA 99167 DVFIMPAAHPVAINA [19] 
47 IFLAGDKDNVIDQ 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
100137 IFLAGDKDNVIDQIEKQAKD [22]; [21] 
47 IFLAGDKDNVIDQ 434746  IFLAGDKDNVIDQIEK + 
MCM(K7) 
[26] 
47 IFLAGDKDNVIDQ 434747 IFLAGDKDNVIDQIEK [26] 
48 FQNLQNHR 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
100445 QRSRQFQNLQNHRIVQIEAK        [29]; [21] 
48 FQNLQNHR 99646  RSRQFQNLQNHRIVQ             [19] 
48 FQNLQNHR 98971 QRSRQFQNLQNHRIV [30]; [24] 
48 FQNLQNHR 99239 FDQRSRQFQNLQNHR              [19] 
48 FQNLQNHR 190748 FDQRSRQFQNLQNHRIVQIE [22] 
48 FQNLQNHR 190757 FQNLQNHRI [22] 
48 FQNLQNHR 190758 FQNLQNHRIVQIEAKPNTLV [22] 
48 FQNLQNHR 40406 FQNLQNHRIVQIEAK [24] 
49 FIMPAAHPVAINA 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
148649 KEGDVFIMPAAHPVAINASS [22]; [29] 
49 FIMPAAHPVAINA 99167 DVFIMPAAHPVAINA [19] 
49 FIMPAAHPVAINA 190764 GDVFIMPAAHPVAINASS [22] 
50 EDFFPASSRDQSSYLQG 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
99243 FFPASSRDQSSYLQG              [19] 
50 EDFFPASSRDQSSYLQG 190749 FEDFFPASSRDQSSYLQGFS [22] 
50 EDFFPASSRDQSSYLQG 524091 QFEDFFPASSRDQSSYLQGFSR
NT 
           [23] 
51 EDFFPASSRDQSSY 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
190749 FEDFFPASSRDQSSYLQGFS [22] 
51 EDFFPASSRDQSSY 524091 QFEDFFPASSRDQSSYLQGFSR
NT 
            [23] 
51 EDFFPASSRDQSSY 99241 FEDFFPASSRDQSSY              [19] 
52 EDFFPASSRDQSS 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
190749 FEDFFPASSRDQSSYLQGFS [22] 
52 EDFFPASSRDQSS 524091 QFEDFFPASSRDQSSYLQGFSR
NT 
            [23] 
52 EDFFPASSRDQSS 99241 FEDFFPASSRDQSSY              [19] 
52 EDFFPASSRDQSS 98955 QFEDFFPASSRDQSS             [30] 
53 EDFFPASSR 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
99241 FEDFFPASSRDQSSY             [19] 
53 EDFFPASSR 98955 QFEDFFPASSRDQSS             [30] 
53 EDFFPASSR 190749 FEDFFPASSRDQSSYLQGFS [22] 
53 EDFFPASSR 524091 QFEDFFPASSRDQSSYLQGFSR
NT 
            [23] 
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53 EDFFPASSR 434773 VAKISMPVNTPGQFEDFFPASS
R + MCM(K3) 
[26] 
53 EDFFPASSR 434774 VAKISMPVNTPGQFEDFFPASS
R 
[26] 
53 EDFFPASSR 99530 PGQFEDFFPASSRDQ              [19] 
53 EDFFPASSR 100400 PVNTPGQFEDFFPASSRDQS             [21] 
53 EDFFPASSR 19983 SMPVNTPGQFEDFFPASSRD [22] 
53 EDFFPASSR 421060 GQFEDFFPASSRDQS [24]; [25] 
54 DLAFPGSGEQVEKL Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
99368 KDLAFPGSGEQVEKL         [25]; [19] 
54 DLAFPGSGEQVEKL 190804 KDLAFPGSGEQVEKLIKNQK [22] 
55 DLAFPGSGEQVEK Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
99368 KDLAFPGSGEQVEKL          [25]; [19] 
55 DLAFPGSGEQVEK 190804 KDLAFPGSGEQVEKLIKNQK [22] 
56 CVYDPR 
Ara h 1 (P43238, N1NG13) 
99385 KLEYDPRCVYDPRGH              [19] 
56 CVYDPR 99782 YDPRCVYDPRGHTGT              [19] 
56 CVYDPR 99919 CVYDPRGHTGTTNQRSPPGE [21] 
56 CVYDPR 100455 RCTKLEYDPRCVYDPRGHTG [21] 
56 CVYDPR 190820 KLEYDPRCVYDPRGHTGTTN [22] 
57 AENNHRIF 
Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
100037 FGINAENNHRIFLAGDKDNV            [21] 
57 AENNHRIF 190771 GINAENNHRIFLAGDKDNVI [22] 
57 AENNHRIF 190988 SSELHLLGFGINAENNHRIF [22] 
57 AENNHRIF 420973 FGINAENNHRIFLAG [24]; [25] 
57 AENNHRIF 521205 LHLLGFGINAENNHRIFLAGDK
DN 
          [23] 
58 CLQSCQQEPDDLKQKA
CESR Ara h 1 (P43238, N1NG13, 
Q6PSU3, P43237,B3IXL2) 
98953 QEPDDLKQKA          [30] 
58 CLQSCQQEPDDLKQKA
CESR 
99129 CQQEPDDLKQKACES           [19] 
58 CLQSCQQEPDDLKQKA
CESR 
99443 LQSCQQEPDDLKQKA           [19] 
59 CMCEALQQIMENQ 
Ara h 2 (Q6PSU2, Q6PSU2-2, 
Q6PSU2-3, Q6PSU2-4) 
53291 RCMCEALQQIMENQSDRLQG [33]; [22]; [34] 
59 CMCEALQQIMENQ 15608 FENNQRCMCEALQQIMENQ [35] 
59 CMCEALQQIMENQ 53290 RCMCEALQQIMENQSDRLQ [35] 
59 CMCEALQQIMENQ 178803 FENNQRCMCEALQQIMENQS [33] 
60 NLPQQCGLRAPQR 
Ara h 2 (Q6PSU2, Q6PSU2-2, 
Q6PSU2-3, Q6PSU2-4) 
33124 KRELRNLPQQCGLRAPQRCD [22]; [34] 
60 NLPQQCGLRAPQR 39150 LRNLPQQCGLRAPQRCDLD [35] 
60 NLPQQCGLRAPQR 99448 LRNLPQQCGLRAPQR [19, 36] 
60 NLPQQCGLRAPQR 105306 LPQQCGLRAPQR [37] 
60 NLPQQCGLRAPQR 179200 LRNLPQQCGLRAPQRCDLDV [33] 
60 NLPQQCGLRAPQR 179375 QFKRELRNLPQQCGLRAPQR [33] 
60 NLPQQCGLRAPQR 514924 ELRNLPQQCGLRAPQRCDLEV
ESG 
[23] 
















Fig. S1. Gel filtration of SDRPs obtained after in vitro oral-gastric phase of digestion of 
whole kernels peanut.  After digestion liquid phase of digestion mixture was precipitated by 
ethanol and non-precipitated solution was applied to Sephadex G-25 column (20 ml of 















   
Figure S2. SDS PAGE profiles of digested and control peanut samples.  A) non-reducing 
conditions; B) reducing conditions. Lane 1- control sample (without amylase and pepsin), 
lane 2 – digested sample, lane 3 – pepsin control at 0`, lane 4 – pepsin control at 120`, M- 
molecular weight markers. 23 µg of peanut proteins and 6 µg of pepsin were applied per lane. 
(C) 1D SDS PAGE profiles of peanut control sample (CPS) and digested peanut sample 
(DPS) analyzed by nLC-MS/MS spectrometry; identification results shown in Table S4. 
Digestibility of peanut proteins from the whole grain was analyzed by non-reducing and 
reducing SDS-PAGE after simulated in vitro oral and gastric digestion (FigS2. A and B). 
Proteins from separated liquid phase of digestion mixture were precipitated by TCA and 
analyzed by SDS PAGE. We have analyzed TCA precipitated protein fraction in order to get 
insight into pepsin resistant protein fraction. TCA was able to precipitate about 30 % of 
protein extracted from peanut during digestion e.g about 10 % of whole peanut grain proteins. 
Under non-reducing conditions (Fig S2.A), at the top of separating gel, high molecular mass 
aggregates of Ara h 1 could be observed in control sample, while they are much less intense 
in digested sample. It was reported that Ara h 1 when transferred from acidic (pH 2) to basic 
(pH 8) environment forms disulfide cross-linked aggregates with mass of about 250 kDa, and 
pepsin digestion destroys ability of Ara h 1 to form these aggregates [38].  In undigested 
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sample there is intensive band in region 55-65 kDa, containing Ara h 1 and disulfide linked 
acidic and basic Ara h 3 subunits [39], while in digested sample intensive series of discrete 
bands in the range 45-65 kDa, originating from proteolysis of Ara h 1 and Ara h 3, could be 
observed instead. Also, bands with Mr of approximately 30, 15 and 12 kDa are more 
intensive in digested sample. Under reducing conditions (Fig S2. B), it is obvious that almost 
all Ara h 1 was proteolyzed mainly to its 50 kDa form, and probably to forms with mass 
about 12 and 16 kDa. Proteolysis of Ara h 3 acidic forms (region 35-45 kDa) is also visible 
under reducing conditions, in contrast to basic forms which looks almost intact. These results 

















Fig. S4 ImmunoCAP absolute values of IgE binding for whole peanut extract, rArah 1, rAra 
h 2, and rAra h 3 inhibited by short digestion resistant peptides (SDRPs) fraction of peptides 
released during peanut gastric digestion. N  noninhibited; I inhibited. X axis’ numbers 






































































Ara h 2 
e) RQQWELQGDRRCQSQLERANLRPCEQHLMQKIQRDEDSYGRDPYSPSQDPYSPSQDPDRRDP
YSPSPYDRRGAGSSQHQERCCNELNEFENNQRCMCEALQQIMENQSDRLQGRQQEQQFKREL
RNLPQQCGLRAPQRCDLEVESGGRDRY    
 








Figure S5. The regions with peptides of Ara h 1 (a, b), Ara h 3 (c, d) and Ara h 2 (e) and Ara 
h 6 (f) found in short digestion resistant peptide (SDRP) fraction of peanut digested by 
pepsin; (a, c) intact peptides, (b, d, e, f) peptides found after reduction, alkylation and trypsin 







epitopes are highlighted in green, and identified short 
digestion resistant peptides (SDRPs) of gastric digesta are in red letters. 
a 
Continuous epitopes 
found by Otsu et al. [40] for Ara h 2 and Ara h 6, Burks et al. [41]  for Ara h 1, and Rouge et 
al. [42]  for Ara h 3. 
b 
Motifs/consensus found in the mimotopes found by Chen et al. [43]  for 























                                                                         
Fig. S6 Hydrophobicity curves of Ara h 1 (A) Ara h 2 (B), Ara h 3 (C) and Ara h 6 (D) with 
underlined regions of peptides found in SDRPs fraction of digested peanut. E) Average 
hydrophobicity scores of Ara h 1, Ara h 2, Ara h 3 and Ara h 6 regions of peptides found in 
SDRPs fraction and whole protein sequence. Hydropathy curves were made by ExPASy - 
ProtScale (web.expasy.org/protscale/), according to Black et al. [45] amino acid scale and 
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Intact SDRPs fraction   of 
Ara h 1 
Trypsin-digested SDRPs 
fraction of Ara h 1 
   
   
   
Fig. S7. Solvent accessible surface of Ara h 1 from three different angles with labelled 
gradual hydrophobicity level (from deep blue for the least hydrophobic to brown for the most 
hydrophobic area). The regions with identified peptides of Ara h 1 found in the short 






     Hydrophobicity                            
Intact SDRPs fraction   of 
Ara h 3 
Trypsin-digested SDRPs 
fraction of Ara h 3 
   
   
   
Fig. S8. Solvent accessible surface of Ara h 3 from three different angles with labelled 
gradual hydrophobicity level (from deep blue for the least hydrophobic to brown for the most 
hydrophobic area). The regions with identified peptides of Ara h 3 found in the short 
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Fig. S9. Solvent accessible surface of Ara h 2 and Ara h 6 from two different angles with 
labelled gradual hydrophobicity level (from deep blue for the least hydrophobic to brown for 
the most hydrophobic area). The regions with identified peptides of Ara h 2 and Ara h 6  
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